Skip to content
Clinical Trials – home

Hospital Virgen De Las Montanas

Verified siteinfo

Spain Paseo Ambulatorio Sn, 11650 Villamartin, Spain

  • 8 trials recruiting
  • Obesity · Arteriosclerosis · Atrial fibrillation
  • Adult patients

About Specializations

Hospital Virgen De Las Montanas in Villamartin, Spain specialises in clinical trials of conditions such as Obesity, Arteriosclerosis, Atrial fibrillation, Cardiac failure, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

At Hospital Virgen De Las Montanas, clinical research in cardiovascular diseases focuses on preventing major heart and blood vessel complications in people with established disease or high risk. The studies explore whether new therapies can lower the chance of heart attack, stroke, urgent revascularization, and cardiovascular death.

  • Prevention of serious events in atherosclerotic cardiovascular disease
  • Studies in elevated lipoprotein(a) and related risk reduction
  • Research in heart failure, including HFpEF and HFmrEF
  • Evaluation of treatments for hypertension and broader high cardiovascular risk

These trials aim to improve treatment effectiveness, reduce future cardiovascular events, and support better long-term outcomes for patients with complex heart and vascular conditions.

Nutritional and Metabolic Diseases

Research in nutritional and metabolic diseases at this site centers on conditions that strongly influence cardiovascular health, especially obesity and type 2 diabetes mellitus. The trials are examining whether newer treatments can support weight reduction, improve blood sugar control, and lower the risk of cardiovascular complications.

  • Studies in obesity and weight-related health problems
  • Clinical research in type 2 diabetes and type 2 diabetes mellitus
  • Trials combining metabolic care with cardiovascular disease prevention
  • Assessment of therapies that may improve both HbA1c and body weight

Overall, the work reflects a strong link between metabolic health and heart disease, with studies designed to test new options for patients living with overlapping cardiometabolic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Paseo Ambulatorio Sn11650 VillamartinSpain
Recruiting now
8 trials
Conditions studied
12
Partner status
Verified site

More sites in VillamartinSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

23 clinical trials

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Cardiac failure

Recruiting

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:POLYPEPTIDE CONSISTING OF A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND AN AMYLIN RECEPTOR AGONIST, CONNECTED BY A LINKER WITH 4 GLYCINE RESIDUES, AND CONNECTED TO A C18 FATTY ACID SIDE CHAIN
  • Sponsor:Novo Nordisk A/S

Cardiac failure

Recruiting

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Obesity+1

Not yet recruiting

Phase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Regeneron Pharmaceuticals Inc.

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Type 2 diabetes mellitus+2

Not yet recruiting

Efficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Regeneron Pharmaceuticals Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.